corresponds to Ca 2ϩ release from intracellular stores. This release component was sensitive to the pharmacological antagonists pyridoxalphosphate-6-azophenyl-2Ј,4Ј-disulphonic acid (PPADS), U73122, neomycin, and heparin (13.5-15 kD), indicating that P2 purinoreceptors (P2Y) and the IP 3 signaling pathway are required for ATP-evoked Ca 2ϩ release. Additionally, a portion of ATP-evoked Ca 2ϩ release was inhibited by ryanodine, a selective blocker of RyRs. The ryanodine-insensitive component (approximately 70%) of ATP-evoked Ca 2ϩ release corresponds to IP 3 -induced Ca 2ϩ release via IP 3 Rs, while the ryanodine-sensitive component (approximately 30%) corresponds to consequent Ca 2ϩ -induced Ca 2ϩ release (CICR) via RyRs. These results indicate that functional IP 3 Rs and RyRs coexist in nodose neurons and that both IP 3 -induced Ca 2ϩ release and CICR can be activated by ATP.
I N T R O D U C T I O N
Cytosolic Ca 2ϩ ions are ubiquitous second messengers that regulate a broad spectrum of cellular processes, including membrane excitability (Hille 2001) , ion channel gating (Hille 2001) , gene expression (Bito et al. 1996) , neurotransmitter release (Katz and Miledi 1968) , muscle contraction (Fabiato and Fabiato 1975) , and secretion of hormones (Curry et al. 1968) and digestive juices (Petersen 1992 ions that trigger CICR arise from Ca 2ϩ influx through plasma membrane voltage-or ligand-gated channels. In contrast, Ca 2ϩ release through IP 3 Rs is activated by increases in [IP 3 ] (IP 3 -induced Ca 2ϩ release). IP 3 is normally generated through cleavage of phosphoinositide lipids by phospholipase C (PLC) coupled to cell-surface receptors (Berridge 1993) .
CICR exists in many types of neurons, including sensory Shmigol et al. 1995) , autonomic (Kuba et al. 1983) , and CNS neurons (Irving et al. 1992; Llano et al. 1994) . We have previously demonstrated the importance of CICR in primary vagal sensory neurons [nodose ganglion neurons (NGNs); for review see Cordoba-Rodriguez et al. 1999] . In NGNs, action potentials trigger transient rises in [Ca 2ϩ ] i (Ca 2ϩ transients), which are produced by Ca 2ϩ influx through voltage-gated Ca 2ϩ channels and the consequent activation of CICR . In a population of NGNs, action potential-induced CICR activates a K ϩ current that underlies a membrane hyperpolarization lasting for several seconds after the action potential [slow afterhyperpolarization (sAHP)]. The major function of the sAHP is to control spike frequency adaptation in these neurons (Weinreich and Wonderlin 1987) . Thus, in this population of NGNs, CICR plays a critical role in regulating membrane excitability.
In the present study, we investigate IP 3 -induced Ca 2ϩ release in NGNs. Using intracellular photorelease of caged IP 3 , we determine that functional IP 3 Rs exist in NGNs. We also show that extracellularly-applied ATP evokes intracellular Ca 2ϩ release through IP 3 signaling. Furthermore, we show that CICR is a component of ATP-evoked Ca 2ϩ release.
M E T H O D S

Cell dissociation
New Zealand White rabbits of either sex, weighing 1-2 kg, were purchased from Harlan Sprague-Dawley (Indianapolis, IN) and killed by pentobarbital sodium overdose (100 mg/kg), as approved by the Institutional Animal Care and Use Committee of the University of Maryland Biotechnology Institute. Dissociated NGNs were prepared as described previously (Leal-Cardoso et al. 1993 ) with the exception that sterile technique was used and the final neuronal pellet was resuspended in Leibovitz L-15 medium (Gibco-BRL, Grand Island, NY) containing 10% fetal bovine serum (FBS; JRH Bioscience, Lenexa, KS). The resulting cell suspension was plated as 0.2 ml aliquots onto 25-mm glass coverslips (Fisher Scientific, Newark, DE) coated with poly-D-lysine (0.1 mg/ml; Sigma, St. Louis, MO). NGNs were incubated at 37°C for 24 h, maintained at room temperature to prevent neurite outgrowth, and used for experiments for Յ72 h.
[Ca 2ϩ ] i measurements and calibration
Loading cells with fura-2 indicator, single-cell microfluorimetry, and calibration of ratiometric data and calculation of [Ca 2ϩ ] i were performed as previously described Kao 1994) .
Fura-2 requires excitation by ultraviolet (UV) light, which could cause adventitious photolysis of caged IP 3 . Therefore fluo-3, which is excited by visible light, was used to monitor [Ca 2ϩ ] i in all photorelease experiments. When fluo-3 was used, cells were loaded with fluo-3/AM in the same manner as fura-2/AM. Single-cell microfluorimetry was performed as previously described , except that excitation was at 490 nm and that the fluorescence emission was passed through a 530-nm band-pass filter before photometric quantitation. We report fluo-3 fluorescence data as changes in fluorescence (⌬F) relative to baseline. The fluo-3 fluorescence intensity record was first corrected by subtracting the background fluorescence intensity, measured after cell lysis with digitonin (20 M). A continuous baseline was obtained by performing a polynomial fit to the segments of the fluo-3 trace recorded between experimental manipulations. This baseline trace was subtracted from the backgroundcorrected record to yield the ⌬F trace.
Unless otherwise stated, the following conventions apply: 1) numerical results are reported as a mean Ϯ SE; 2) when multiple responses were elicited from a NGN, the response amplitude under a given experimental condition was normalized to the control response amplitude; and 3) Student's t-test (two-tailed) was used to assess significant differences between calculated means (P Ͻ 0.05 was considered significant).
Immunofluorescence microscopy SOLUTIONS AND ANTIBODIES. Phosphate buffered saline (PBS) consisted of the following (in mM): 145 NaCl, 10 Na phosphate, and 10 NaN 3 , pH 7.2. FBS-azide-NaCl-Tris (FANT) solution (1% or 10%) consisted of the following: 1% or 10% (vol/vol) fetal bovine serum, 10 mM NaN 3 , 0.5 M NaCl, and 20 mM Tris, pH 7.2 (at 4°C). p-Phenylenediamine (PPD)-glycerol consisted of the following: 100 mg PPD dissolved in 10 ml of 1 M Tris (pH 8.5) mixed with 90 ml glycerol. Affinity-purified goat anti-IP 3 R antibodies (GT328, raised against purified rat cerebellar IP 3 Rs) and sheep anti-RyR antibodies (sheep 7037227), raised against purified rabbit skeletal RyRs, were gifts from Dr. Allan Sharp (Johns Hopkins University, Baltimore, MD) and Dr. Kevin Campbell (University of Iowa, Iowa City, IA), respectively. Fluorescent secondary antibodies (fluorescein-labeled donkey-anti-goat and donkey-anti-sheep) were purchased from Jackson Immunoresearch Laboratories, Inc. (West Grove, PA).
ANTIBODY LABELING. NGNs plated on poly-D-lysine-coated No. 1 glass coverslips were washed in PBS, fixed in 2% paraformaldehyde in PBS for 15 min, washed three times in PBS, quenched 50 min in 0.1 M glycine in PBS (pH 8), permeabilized for 5 min in 0.5% Triton in PBS, and given three 20-min incubations in 10% FANT, followed by three 10-min incubations in 1% FANT. The neurons were labeled with primary antibody (goat-anti-IP 3 R or sheep anti-RyR) for 20 h and washed for 8 h in 1% FANT; the wash solution was exchanged at 20-min intervals. Subsequently, the NGNs were labeled with fluorescent secondary antibody for 20 h and washed for 8 h in 1% FANT; the wash solution was exchanged at 40-min intervals.
CONFOCAL IMAGING. Coverslips bearing labeled NGNs were mounted in PPD-glycerol and examined on a laser scanning confocal microscope fitted with a ϫ63 oil-immersion objective with a N.A. of 1.4 (Model LSM 410; Carl Zeiss, Inc., New York). Fluorophores were excited by 488-nm light from an argon ion laser, and fluorescence emission was acquired through a 515-to 565-nm band-pass filter. A single 1.09-m optical section was taken through the thickest part of each NGN.
Physiological saline solutions
EXTRACELLULAR SOLUTION. Neurons were superfused with physiological saline solution (21-24°C) that contained the following (in mM): 120 NaCl, 3.0 KCl, 1.0 NaH 2 PO 4 , 25.0 NaHCO 3 , 1.5 MgCl 2 , 2.2 CaCl 2 , and 10.0 dextrose, equilibrated with 95%O 2 -5%CO 2 and pH adjusted to 7.2-7.4. For experiments where nominally Ca 2ϩ -free medium was required, CaCl 2 was omitted.
INTRACELLULAR SOLUTION. Patch-pipette stock solutions contained the following (in mM): 152 KCH 3 SO 3 , 10.0 HEPES, 2.0 MgCl 2 , 1.0 Na 3 ATP, 1.0 Na 3 GTP, and 1.0 KCl; pH adjusted with KOH to 7.2. KCH 3 SO 3 was used to avoid excess intracellular Cl Ϫ , which is known to inhibit G proteins (Lenz et al. 1997) . Aliquots of stock pipette solution were stored frozen at 0°C. Each aliquot of pipette solution was thawed, stored on ice, and used for only 1 d. K 5 Fluo-3 was added to the pipette solution to a final concentration of 50 M; sufficient CaCl 2 was added to set free [Ca 2ϩ ] ϭ 100 nM (taking the Ca 2ϩ dissociation constant of fluo-3 under physiological conditions to be 400 nM; Minta et al. 1989 ). For photolysis experiments, 0.5 mM of the trisodium salt of D-myo-inositol 1,4,5-trisphosphate P 4(5) -1-(2-nitrophenyl)ethyl ester (caged IP 3 ) was included in the pipette solution, which was loaded only into the tip of the pipette. The shaft of the pipette was filled with pipette solution containing no caged IP 3 . For experiments using fura-2, the pipette solution contained 50 M K 5 Fura-2 and sufficient CaCl 2 to set [Ca 2ϩ ] i ϭ 100 nM (taking the Ca 2ϩ dissociation constant of fura-2 under physiological conditions to be 224 nM; Grynkiewicz et al. 1985) .
Reagent delivery
EXTRACELLULAR REAGENT DELIVERY. A custom recording chamber with a narrow rectangular flow path provided 7 ml/min superfusion of NGNs on a No. 1 glass coverslip via a gravity flow system. The chamber was mounted on the stage of an inverted microscope (Diaphot; Nikon, Melville, NY) equipped with a ϫ40 phase-contrast oil-immersion objective (Fluor, N.A. 1.3; Nikon) to allow fluorescence measurements or direct visualization of NGNs. In experiments where drugs were applied in Ca 2ϩ -free solution, nominally Ca 2ϩ -free physiological saline was superfused for Ն10 s before and after drug application. Solution changes were complete in 14 s, as determined with fluorescent tracers.
INTRACELLULAR REAGENT DELIVERY. The whole cell configuration of the patch-clamp technique was used to deliver membraneimpermeant reagents (caged IP 3 and heparin). Patch pipettes (2-3 M⍀), fabricated from 1.5 mm OD borosilicate glass stock (World Precision Instruments, Sarasota, FL) on a Flaming-Brown P97 micropipette puller (Sutter Instruments, Novato, CA), were used with an Axopatch 200B amplifier (Axon Instruments, Union City, CA). NGNs were first loaded with fluo-3/AM or fura-2/AM. After forming a gigaohm seal (Ͼ1.0 G⍀), the whole cell configuration was established, with neurons voltage clamped to Ϫ50 mV. Neurons were considered suitable for study if membrane input resistance was Ͼ150 M⍀, holding current was Ͻ200 pA, and resting [Ca 2ϩ ] i was Յ100 nM. Because heparin can activate RyRs (Bezprozvanny et al. 1993) , when heparin was used intracellularly, Ry (10 M) was also included in the intracellular solution.
FLASH PHOTOLYSIS OF CAGED IP 3 . To photolyze caged IP 3 , we delivered 500-ms flashes of UV light to NGNs loaded with caged IP 3 . The multiline UV output (333.6 -363.8 nm) of an argon ion laser (BeamLok 2065-7S; Spectra-Physics, Mountain View, CA) was used for photolysis. The output beam of the laser was directed through an objective lens (U-27X; Newport Corp., Irvine, CA) and focused onto the cleaved 50-m diam silica core of a step-index multimode optical fiber (CeramOptec, East Longmeadow, MA). For adjusting alignment, the objective lens and the chuck holding the optical fiber were both mounted on a multimode fiber coupler assembly (F-915T; Newport Corp.). The output end of the optical fiber was sheathed in a glass pipette, which was mounted on a hydraulic micromanipulator to allow the output of the fiber to be directed onto cells being viewed under the microscope. The duration of UV flashes was regulated by a laser shutter (LS200F; NM Laser Products, Sunnyvale, CA) interposed between the laser head and the UV objective lens of the coupler. Shutter gating was controlled by TTL signals through pClamp8 software (Axon Instruments).
Reagents
Reagents were obtained from the following sources: caffeine from Sigma-Aldrich (Milwaukee, WI); ryanodine, caged IP 3 , and heparin (13.5-15 kD) from Calbiochem (La Jolla, CA); acetoxymethyl esters of fura-2 (fura-2/AM) and fluo-3 (fluo-3/AM) and pentapotassium salts of fura-2 and fluo-3 from Teflabs, Inc. (Austin, TX); and neomycin, U73122, ATP␥S, UTP, PPADS, and ATP from Alexis Biochemicals (San Diego, CA). Inorganic salts were from VWR (Piscataway, NJ).
Reagent solutions were prepared daily from concentrated stock solutions in dimethylsulfoxide (Fisher Biotech, Fair Lawn, NJ) or water that were stored frozen. Unless otherwise noted, drugs were delivered via the superfusate by switching a three-way valve to a reservoir containing a known concentration of the drug in the extracellular solution.
Reagent concentrations were as follows: ATP and ATP␥S, 100 M; UTP, 300 M; caged IP 3 , 500 M; caffeine, 10 mM; ryanodine and PPADS, 10 M; neomycin, 2 mM; U73122, 1 M; and heparin (13.5-15 kD), 1 mg/ml.
R E S U L T S
Functional RyRs mediating robust CICR existed in all primary vagal sensory neurons (NGNs) examined Hoesch et al. 2001 ). In the current work, we ask whether IP 3 Rs, another type of intracellular Ca 2ϩ release channel, are co-expressed with RyRs in NGNs. To provide functional evidence for the co-expression of RyRs and IP 3 Rs, we loaded NGNs with caged IP 3 via whole cell patch pipettes and used fluo-3 to monitor [Ca 2ϩ ] i , as shown in Fig. 1 . We first confirmed the presence of functional RyRs by applying caffeine, the classic pharmacological agonist of RyRs, in Ca 2ϩ -free medium (Hoesch et al. 2001 Immunofluorescence confocal microscopy also revealed that NGNs express both RyRs and IP 3 Rs. labeled with anti-RyR or anti-IP 3 R primary antibodies, and labeled with fluorescent secondary antibodies. These optical sections reveal both anti-RyR and anti-IP 3 R staining, further supporting the conclusion that RyRs and IP 3 Rs are both expressed in NGNs. In total, we imaged 29 anti-RyR-labeled NGNs and 36 anti-IP 3 R-labeled NGNs. It is interesting to note that the subcellular distributions of RyR and IP 3 R staining show some subtle differences. Anti-RyR staining occurs in two regions: a thin cortical band of staining, which is presumably sub-plasma membrane, and a larger region of staining in the interior of the cell. In contrast, anti-IP 3 R staining appears to be more uniformly distributed throughout the cell. Moreover, bright punctate anti-IP 3 R staining in the interior of the neurons was frequently observed, while anti-RyR staining tended to be more homogeneous in intensity. The significance of these apparent differences is not clear.
IP 3 photorelease consistently evoked Ca 2ϩ transients in all NGNs tested (40 of 40). We sought to confirm that these Ca 2ϩ transients evoked by IP 3 photorelease required functional IP 3 Rs and resulted from release of Ca 2ϩ from intracellular stores. When heparin, an IP 3 R antagonist (Ehrlich et al. 1994) , was included with caged IP 3 in the patch pipette, IP 3 photorelease did not evoke a detectable Ca 2ϩ transient (Fig. 3, n ϭ 3 ). Same-cell controls were not possible in heparin experiments because heparin was included in the pipette solution with caged IP 3 , and thus was present throughout recording. Because heparin can activate RyRs (Bezprozvanny et al. 1993) the presence and absence of extracellular Ca 2ϩ . In eight NGNs, the amplitudes of control pairs of ATP-evoked Ca 2ϩ transients (Fig. 4 , peaks 1 and 1Ј) averaged 576 Ϯ 157 and 520 Ϯ 112 nM, respectively, whereas those recorded in Ca 2ϩ -free medium averaged 379 Ϯ 91 nM. On average, 70.0 Ϯ 5.0% of the amplitude of the ATP-evoked Ca 2ϩ signal persists in the nominal absence of extracellular Ca 2ϩ (Fig. 4, peak 2 In other systems, ATP activates P2 purinoreceptors to trigger intracellular Ca 2ϩ release (for review, see Dubyak and el-Moatassim 1993) . To implicate P2Y receptors in ATPevoked Ca 2ϩ release in NGNs, we examined the effects of PPADS, a P2 purinoreceptor antagonist (Lambrecht et al. 1992 ), on ATP-evoked Ca 2ϩ transients in Ca 2ϩ -free medium. In the presence of PPADS, ATP-evoked Ca 2ϩ release was significantly inhibited (Fig. 5A) , averaging only 17.6 Ϯ 3.5% of control values (Table 1) . These results suggest that P2Y receptors are required for ATP-evoked Ca 2ϩ release. To examine in more detail the involvement of P2Y receptors in Ca 2ϩ release, we compared the efficacy of several nucleotides: ATP␥S, ATP, and UTP. For these studies, we measured peak 1 P2X-mediated Na ϩ influx could conceivably influence ATP-evoked Ca 2ϩ signaling by changing the driving force for Na ϩ /Ca 2ϩ exchange (Blaustein and Lederer 1999 release evoked by a 30-s pulse of ATP (peak 1). To maximize sequestration of phosphoinositides before the start of measurement, NGNs were incubated with neomycin (2 mM) for Ն1 h. Washout of neomycin partially restored ATP-evoked Ca 2ϩ release (peak 2). D: 30-s pulse of ATP evoked intracellular Ca 2ϩ release (peak 1). Heparin (Hep; 1 mg/ml), an IP 3 receptor antagonist, inhibited ATP-evoked Ca 2ϩ release (peak 2). Arrowhead marks the time when the whole cell configuration was established and intracellular delivery of heparin began. The break in the trace corresponds to the time interval (131 s) during which the patch pipette was positioned to form a gigaohm seal. Bars below the traces mark durations of reagent application. Fura-2 was used to measure [Ca 2ϩ ] i .
agonist-evoked Ca 2ϩ transients in the absence of extracellular Ca 2ϩ , and normalized the peak value for a given agonist to the peak value for ATP in each NGN. Compared with ATP-evoked Ca 2ϩ release, ATP␥S-evoked Ca 2ϩ release averaged 110 Ϯ 30% for 7 NGNs, and UTP-evoked Ca 2ϩ release averaged 16.0 Ϯ 5.0% for 10 NGNs (responses not shown), indicating that ATP and ATP␥S have similar efficacy for Ca 2ϩ release and that both are significantly more effective than UTP. Such a rank-order of potency (ATP␥S Ն ATP Ͼ Ͼ UTP) does not match the published order for activation of any specific cloned P2Y receptor subtype (King et al. 1998) , suggesting that more than one P2Y receptor subtype may be expressed in rabbit NGNs.
We probed the role of the IP 3 signaling pathway in ATPevoked Ca 2ϩ release by applying three antagonists: U73122, an inhibitor of PLC (Lee et al. 1998); neomycin (Neo), which complexes phosphoinositide lipids to render them unavailable as PLC substrates (Carney et al. 1985) ; and heparin (13.5-15 kD, Hep), an IP 3 R antagonist (Ehrlich et al. 1994 ). Representative records showing inhibition of ATP-evoked Ca 2ϩ release by each antagonist are shown in Fig. 5, (B-D) , respectively. For each experiment, ATP-evoked Ca 2ϩ release was measured in the presence and absence of antagonist. As shown in Fig. 5  (B-D) , ATP-evoked Ca 2ϩ release in the presence of antagonist was significantly reduced compared with control. The aggregate results from groups of NGNs treated as in Fig. 5 are summarized in Table 1 . As shown in Table 1 , each of the antagonists tested (U73122, Neo, and Hep) significantly inhibited ATP-evoked Ca 2ϩ release, with inhibition ranging from 50 to 95%. Taken together, these data strongly suggest that ATPevoked Ca 2ϩ release is mediated by the IP 3 signaling pathway. We note that none of the antagonists blocked ATP-evoked Ca 2ϩ release completely. Inhibition of PLC by U73122 was most effective in blocking ATP-evoked Ca 2ϩ release (95%). Sequestration of phosphoinositide substrates of PLC by neomycin appeared less effective (50%). Neomycin's inhibitory efficacy was likely underestimated in these experiments because same-cell control response was measured after neomycin washout. Washout of neomycin, a polycationic aminoglycoside, is expected to be inefficient and, thus may have been incomplete. Although heparin was quite effective in inhibiting ATP-induced Ca 2ϩ release (63%), inhibition was nonetheless incomplete. In light of our finding that heparin completely inhibited the Ca 2ϩ response evoked by IP 3 photorelease, the reduced effectiveness of heparin in blocking ATP-evoked Fig. 7 .
Previously, we observed that all NGNs exhibit robust CICR Hoesch et al. 2001) , implying that all NGNs express functional RyRs. In the present study, intracellular photorelease of IP 3 triggered Ca 2ϩ release in all 40 NGNs tested. This suggests that all rabbit NGNs also express functional IP 3 receptors. Indeed, application of caffeine, the classic RyR agonist, and IP 3 photorelease both evoked Ca 2ϩ release in the same NGNs (Fig. 1) . Immunofluorescence localization of antibodies to RyRs and IP 3 Rs in NGNs further support these conclusions (Fig. 2) . Together, these observations imply that functional IP 3 Rs and RyRs coexist in the same NGNs.
The observation that intracellular Ca 2ϩ release occurs through both IP 3 Rs and RyRs in NGNs is significant for several reasons. First, that IP 3 Rs and RyRs coexist in the soma of NGNs suggests that IP 3 Rs and RyRs might also coexist within the central and peripheral processes of NGNs. Second, their different mechanisms of activation could allow both IP 3 Rs and RyRs to be activated independently in response to complex stimuli such as peripheral inflammation. During inflammation, a variety of extracellular inflammatory mediators, such as 5-HT, bradykinin, and ATP, stimulate NGNs to fire action potentials (Undem and Carr 2001), which are known to activate CICR via RyRs . Inflammatory mediators such as ATP (Dubyak and el-Moatassim 1993) could also simultaneously activate the IP 3 signaling pathway, leading to Ca 2ϩ release via IP 3 Rs. The consequent, amplified rise in [Ca 2ϩ ] i might then activate other cellular processes, including gene expression, an example of which could be the allergic inflammation-induced preprotachykinin gene expression in airway-projecting NGNs (Fischer et al. 1996) . Third, since IP 3 Rs and RyRs coexist, and their spatial distributions apparently overlap (Fig. 2) , it is conceivable that Ca 2ϩ could be released via IP 3 Rs and RyRs from a common Ca 2ϩ pool in NGNs, as has been shown in cerebellar Purkinje neurons (Khodakhah and Armstrong 1997). Alternatively, despite the overlapping spatial distributions of IP 3 Rs and RyRs, the two channels may mediate Ca 2ϩ release from distinct Ca 2ϩ pools, as was observed in astrocytes and arterial myocytes Blaustein 1997, 2000) . Distinguishing between these two alternatives requires further experimentation.
The existence of functional IP 3 Rs in NGNs raises the question of the nature of the stimulus that might activate these receptors physiologically. ATP is one of many metabotropic agonists known to act through the IP 3 signaling pathway in other cells (Dubyak and el-Moatassim 1993) . In the present work, ATP consistently evoked Ca 2ϩ transients, which were predominantly (approximately 70%) attributable to intracellular Ca 2ϩ release. In all NGNs tested, ATP could activate intracellular Ca 2ϩ release that required metabotropic (P2Y) purinoreceptors and the IP 3 signaling pathway. However, P2Y receptors are unlikely to be the only receptors in NGNs that can signal through the IP 3 pathway. Metabotropic glutamate receptors (mGluRs), which are known to use the IP 3 signaling pathway in other cell types (Aramori and Nakanishi 1992), have been studied in (Hay and Kunze 1994) and recently cloned from rat NGNs (Hoang and Hay 2001) . It is thus possible that the IP 3 signaling pathway in NGNs, in addition to being activated by ATP, may also be activated by glutamate, another physiological agonist.
NGNs are a heterogeneous collection of primary afferents that convey sensory information spanning a wide spectrum of modalities, including mechano-, thermo-, and chemo-sensation, from a broad range of visceral structures, including the small intestine, trachea, lungs, great vessels, and the stomach. In light of such diversity, the finding that all NGNs exhibit ATP-evoked Ca 2ϩ transients that are mediated in part by IP 3 Rs is of particular physiological interest. A role for ATP in nociceptive mechanosensory transduction in tubular (salivary duct, bile duct, vagina, and intestine) and saccular (urinary bladder, gall bladder, and lung) structures was recently hypothesized by Burnstock (2001) . It was proposed that nerve fibers innervating the walls of such structures are sensitive to ATP released from distressed or damaged mucosal epithelial cells during mechanical stimulation (e.g., distension). Peripheral endings of NGNs also innervate tubular and saccular structures (intestine, blood vessels, stomach, trachea, and lungs) that are lined by epithelial cells. Therefore if NGN peripheral nerve endings, like the soma, are sensitive to ATP, then ATP released from damaged epithelial cells could stimulate NGN peripheral nerve endings by activating P2X and P2Y receptors. Activated P2X receptors conduct inward currents carried by Na ϩ and Ca 2ϩ ions (Thomas et al. 1998; Virginio et al. 1998) by activating K ϩ channels, triggers a slow afterhyperpolarization (sAHP), which controls spike frequency adaptation (Moore et al. 1998; Weinreich and Wonderlin 1987) . Our present study shows that ATP activates IP 3 Rs and that Ca 2ϩ released through IP 3 Rs can activate CICR. Therefore ATP, as well as other metabotropic agonists, may control neuronal excitability through regulation of ion channels by IP 3 -evoked Ca 2ϩ release and/or consequent Ca 2ϩ -induced Ca 2ϩ release (see Fig. 7 ).
